Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The mesenchymal stem cell secretome as an acellular regenerative therapy for liver disease
Julia Driscoll, Tushar Patel
Journal of Gastroenterology (2019) Vol. 54, Iss. 9, pp. 763-773
Open Access | Times Cited: 141

Showing 1-25 of 141 citing articles:

Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy In Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use
Laxmaiah Manchikanti
Pain Physician (2020) Vol. 2;23, Iss. 4;2, pp. E71-E83
Open Access | Times Cited: 229
Therapeutic potential and mechanisms of mesenchymal stem cell-derived exosomes as bioactive materials in tendon–bone healing
Jiaxuan Zou, Weinan Yang, Wushi Cui, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 170
Mesenchymal Stem Cell-Derived Secretome: A Potential Therapeutic Option for Autoimmune and Immune-Mediated Inflammatory Diseases
Györgyi Műzes, Ferenc Sípos
Cells (2022) Vol. 11, Iss. 15, pp. 2300-2300
Open Access | Times Cited: 105
Potential pre-activation strategies for improving therapeutic efficacy of mesenchymal stem cells: current status and future prospects
Meirong Li, Yufeng Jiang, Qian Hou, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 79
Mesenchymal stromal cells in hepatic fibrosis/cirrhosis: from pathogenesis to treatment
Xue Yang, Qing Li, Wenting Liu, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 6, pp. 583-599
Open Access | Times Cited: 50
Mesenchymal stromal cells promote liver regeneration through regulation of immune cells
Chenxia Hu, Zhongwen Wu, Lanjuan Li
International Journal of Biological Sciences (2020) Vol. 16, Iss. 5, pp. 893-903
Open Access | Times Cited: 111
Mesenchymal stem cell-derived extracellular vesicle-based therapies protect against coupled degeneration of the central nervous and vascular systems in stroke
Abolfazl Rahmani, Kiarash Saleki, Nima Javanmehr, et al.
Ageing Research Reviews (2020) Vol. 62, pp. 101106-101106
Closed Access | Times Cited: 83
Exosomes derived from umbilical cord mesenchymal stem cells alleviate viral myocarditis through activating AMPK/mTOR‐mediated autophagy flux pathway
Xiaohong Gu, Yuechun Li, Kaixin Chen, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 13, pp. 7515-7530
Open Access | Times Cited: 80
Mesenchymal Stem Cells as a Cornerstone in a Galaxy of Intercellular Signals: Basis for a New Era of Medicine
Silvia Fernández-Francos, Noemí Eiró, Luis A. Costa, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3576-3576
Open Access | Times Cited: 79
Nitric oxide modulation in neuroinflammation and the role of mesenchymal stem cells
Pan M Liy, Nur Nabilah Ahmad Puzi, Shinsmon Jose, et al.
Experimental Biology and Medicine (2021) Vol. 246, Iss. 22, pp. 2399-2406
Open Access | Times Cited: 72
Mesenchymal Stromal Cell Secretome for the Treatment of Immune-Mediated Inflammatory Diseases: Latest Trends in Isolation, Content Optimization and Delivery Avenues
Elena Munoz-Perez, Ainhoa Gonzalez‐Pujana, Manoli Igartúa, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1802-1802
Open Access | Times Cited: 58
Mesenchymal (Stem) Stromal Cells Based as New Therapeutic Alternative in Inflammatory Bowel Disease: Basic Mechanisms, Experimental and Clinical Evidence, and Challenges
Noemí Eiró, María Fraile, Alberto González-Jubete, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 8905-8905
Open Access | Times Cited: 40
Mesenchymal Stromal Cells as a Driver of Inflammaging
Svetlana Lyamina, Denis Baranovskii, Ekaterina Kozhevnikova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6372-6372
Open Access | Times Cited: 30
Wharton’s jelly mesenchymal stem cells: a concise review of their secretome and prospective clinical applications
Hana Drobiova, Sardar Sindhu, Rasheed Ahmad, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 23
Pre‐treatments enhance the therapeutic effects of mesenchymal stem cells in liver diseases
Chenxia Hu, Zhongwen Wu, Lanjuan Li
Journal of Cellular and Molecular Medicine (2019) Vol. 24, Iss. 1, pp. 40-49
Open Access | Times Cited: 71
Epigenetic reprogramming enhances the therapeutic efficacy of osteoblast‐derived extracellular vesicles to promote human bone marrow stem cell osteogenic differentiation
Kenny Man, Mathieu Brunet, María Fernández‐Rhodes, et al.
Journal of Extracellular Vesicles (2021) Vol. 10, Iss. 9
Open Access | Times Cited: 56
Mesenchymal Stem Cell-Based Therapy as an Alternative to the Treatment of Acute Respiratory Distress Syndrome: Current Evidence and Future Perspectives
Silvia Fernández-Francos, Noemí Eiró, Natalia González-Galiano, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 7850-7850
Open Access | Times Cited: 55
Characteristics and regulation of mesenchymal stem cell plasticity by the microenvironment — specific factors involved in the regulation of MSC plasticity
Liping Tan, Xuan Liu, Huan Dou, et al.
Genes & Diseases (2020) Vol. 9, Iss. 2, pp. 296-309
Open Access | Times Cited: 50
Human Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Acquire Rejuvenation and Reduced Heterogeneity
Wasco Wruck, Nina Graffmann, Lucas‐Sebastian Spitzhorn, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 44
Human amniotic mesenchymal stem cells-derived IGFBP-3, DKK-3, and DKK-1 attenuate liver fibrosis through inhibiting hepatic stellate cell activation by blocking Wnt/β-catenin signaling pathway in mice
Quanwen Liu, Yan-Min Ying, Jiaxin Zhou, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 38
Mesenchymal stromal cells: promising treatment for liver cirrhosis
Lichao Yao, Xue Hu, Kai Dai, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 36
Aging and Mesenchymal Stem Cells: Basic Concepts, Challenges and Strategies
María Fraile, Noemí Eiró, Luis A. Costa, et al.
Biology (2022) Vol. 11, Iss. 11, pp. 1678-1678
Open Access | Times Cited: 35
Recent Advancements in Antifibrotic Therapies for Regression of Liver Fibrosis
Anshika Jangra, Ashish Kothari, Phulen Sarma, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1500-1500
Open Access | Times Cited: 33
Therapeutic Potential of Mesenchymal Stem Cell-Derived Extracellular Vesicles to Treat PCOS
Hang-Soo Park, Esra Çetin, Hiba Siblini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11151-11151
Open Access | Times Cited: 22
Efficacy and safety of mesenchymal stem cell therapy in liver cirrhosis: a systematic review and meta-analysis
Wenming Lu, Jiayang Qu, Longxiang Yan, et al.
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top